Grindex

Grindeks is a prominent pharmaceutical company based in Riga, Latvia, and is the largest manufacturer of medicines in the Baltic States. The company focuses on the research, development, and production of original products, generic medications, and active pharmaceutical ingredients (APIs). Its primary therapeutic specializations include cardiovascular diseases, central nervous system disorders, oncology, and diabetes. Grindeks is globally recognized for its original drug Mildronate (meldonium), which remains a cornerstone of its cardiovascular portfolio. With a strong export orientation, the company delivers products to more than 100 countries and maintains manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards.